Quent Capital, LLC Horizon Therapeutics Public LTD CO Transaction History

Quent Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jun 14, 2024	BUY	$98.98 - $115.74 $10,887 - $12,731	110 Added 5.46%	2,125 $245,000
Q3 2023 Oct 10, 2023	BUY	$98.98 - $115.74 $10,887 - $12,731	110 Added 5.46%	2,125 $245,000
Q1 2023 Jun 14, 2024	BUY	$107.32 - $113.5 $216,249 - $228,702	2,015 New	2,015 $219,000
Q1 2023 Apr 05, 2023	BUY	$107.32 - $113.5 $2,039 - $2,156	19 Added 0.95%	2,015 $219,000
Q4 2022 Jan 19, 2023	BUY	$62.39 - $113.8 $1,684 - $3,072	27 Added 1.37%	1,996 $0

Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $9,427 - $13,547	160 Added 8.84%	1,969 $122,000
Q2 2022 Aug 08, 2022	SELL	$79.4 - $116.36 $11,195 - $16,406	-141 Reduced 7.23%	1,809 $144,000
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $37,506 - $47,657	434 Added 28.63%	1,950 $205,000
Q4 2021 Feb 28, 2022	BUY	$98.56 - $119.91 $149,416 - $181,783	1,516 New	1,516 $163,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Quent Capital, LLC with notifications on news.